Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis

Published:2022-06-24 Issue:4 Volume:11 Page:1661-1682
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Xie Jing,Xu Bin,Wei Linlin,Huang Chunyang,Liu Wei

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-022-00666-0.pdf

Reference52 articles.

1. Jing W, Liu J, Liu M. Global trends and regional differences in hepatitis C virus infection prevalence and implications for prevention—worldwide, 1990–2017. China CDC Wkly. 2020;2(30):564–9.

2. Di Marco L, La Mantia C, Di Marco V. Hepatitis C: standard of treatment and what to do for global elimination. Viruses. 2022;14(3):505.

3. Kohli A, Shaffer A, Sherman A, et al. Treatment of hepatitis C: a systematic review. JAMA. 2014;312(6):631–40.

4. Klein MB. Simplifying HCV treatment: a pathway to elimination and model for delivering health care to vulnerable populations. Lancet Gastroenterol Hepatol. 2022;7:277–9.

5. Benítez-Gutiérrez L, Barreiro P, Labarga P, et al. Prevention and management of treatment failure to new oral hepatitis C drugs. Expert Opin Pharmacother. 2016;17(9):1215–23.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO’s Targets in Ontario, Canada;Viruses;2024-07-31

2. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02

3. Effects of comorbid conditions and prescribed chronic medications on the treatment plan for chronic hepatitis C infection: A cross‐sectional retrospective study;Health Science Reports;2024-04-29

4. Universal screening for HCV infection in China: An effectiveness and cost-effectiveness analysis;JHEP Reports;2024-04

5. Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India;Journal of Clinical and Experimental Hepatology;2024-03